Impact of Infections in Patients with Acute Myeloid Leukemia Receiving Cytarabine+ Daunorubicin (7+3) Versus Azacitidine and Venetoclax during Induction Chemotherapy. (2025). Indus Journal of Bioscience Research, 3(1), 190-196. https://doi.org/10.70749/ijbr.v3i1.469